Hsinchu, Taiwan

Shing Mein Wu

This inventor holds 1 USPTO granted patent. Top assignee: Industrial Technology Research Institute. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shing Mein Wu. Retrieved from https://idiyas.com/inventor/shing-mein-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shing Mein Wu: Innovator in Pharmaceutical Composition

Introduction

Shing Mein Wu is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on oligopeptides.

Latest Patents

Wu holds a patent for NAP derivatives, which includes an oligopeptide comprising formulae (I) or (II) and the oligopeptide derivative thereof. This patent also encompasses a pharmaceutical composition that utilizes these derivatives, showcasing his expertise in developing new therapeutic options.

Career Highlights

Wu is affiliated with the Industrial Technology Research Institute, where he has been instrumental in advancing research and development in his field. His work has not only contributed to scientific knowledge but also has practical applications in medicine.

Collaborations

He has collaborated with notable colleagues, including On Lee and Jenn-Tsang Hwang, to further enhance the impact of their research and innovations.

Conclusion

Shing Mein Wu's contributions to the pharmaceutical industry through his patent on NAP derivatives exemplify his role as a leading inventor in the field. His work continues to influence advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…